Cargando…
EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study
BACKGROUND/AIMS: The novel prostaglandin E (EP) 3 and prostaglandin F (FP) receptor agonist ONO-9054 is effective in lowering intraocular pressure (IOP) in patients with ocular hypertension and open-angle glaucoma when administered once daily. This study compares the effects of morning (AM) versus e...
Autores principales: | Berlin, Michael S, Rowe-Rendleman, Cheryl, Ahmed, Ike, Ross, Douglas T, Fujii, Akifumi, Ouchi, Takafumi, Quach, Christine, Wood, Andrew, Ward, Caroline L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893083/ https://www.ncbi.nlm.nih.gov/pubmed/26453641 http://dx.doi.org/10.1136/bjophthalmol-2015-307000 |
Ejemplares similares
-
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study
por: Miller Ellis, Eydie, et al.
Publicado: (2017) -
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
por: Eastell, R., et al.
Publicado: (2015) -
Morning and evening exercise
por: Seo, Dae Yun, et al.
Publicado: (2013) -
On the Comparative Frequency of the Morning and Evening Pulse
por: Stratton, Thomas
Publicado: (1843) -
Post-Exercise Hypotension and Its Mechanisms Differ after Morning and Evening Exercise: A Randomized Crossover Study
por: de Brito, Leandro C., et al.
Publicado: (2015)